Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marc-Andre Coté"'
Autor:
Miran, Kenk, Jean C, Grégoire, Marc-Andre, Coté, Kim A, Connelly, Margot K, Davis, George, Dresser, Nina, Ghosh, Shaun, Goodman, Christopher, Johnson, Neil, Fleshner
Publikováno v:
Can Urol Assoc J
In clinical practice, cancer management does not consistently encompass screening and identification of cardiovascular (CV) risk. The use of androgen deprivation therapy (ADT) in prostate cancer has been associated with increased CV risk and developm
Autor:
Chris A. Johnson, Jean Grégoire, Kim A. Connelly, Miran Kenk, Neil Fleshner, Margot K. Davis, Nina Ghosh, George K. Dresser, Shaun G. Goodman, Marc-Andre Coté
Publikováno v:
Canadian Urological Association Journal. 14
In clinical practice, cancer management does not consistently encompass screening and identification of cardiovascular (CV) risk. The use of androgen deprivation therapy (ADT) in prostate cancer has been associated with increased CV risk and developm
Autor:
Paaladinesh Thavendiranathan, Tomoko Negishi, Marc-Andre Coté, Martin Penicka, Richard Massey, Goo-Yeong Cho, Krassimira Hristova, Dragos Vinereanu, Bogdan A. Popescu, Masaki Izumo, Kazuaki Negishi, Thomas H. Marwick, Svend Aakhus, Manish Bansal, Andreea Calin, Jelena Celutkiene, Nobuyuki Fukuda, Andre La Gerche, Julie Lemieux, Diana Mihalcea, Philip Mottram, Ryoko Morimoto Ichikawa, Mark Nolan, Tomas Ondrus, Stéphanie Seldrum, Mitra Shirazi, Evgeny Shkolnik, Babitha Thampinathan, Liza Thomas, Hirotsugu Yamada, Satoshi Yuda, Eitan Amir
Publikováno v:
JACC: Cardiovascular Imaging. 11:1109-1118
The goal of this study was to compare echocardiographic measurements of global longitudinal strain (GLS) (using 3 apical views) with single-view longitudinal strain (LS, 4- or 2-chamber [4CV_LS and 2CV_LS, respectively]) for detection of cancer-thera
Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin
Autor:
Erwan Salaun, Samuel Drory, Marc‐André Coté, Veronic Tremblay, Elisabeth Bédard, Christian Steinberg, David Paré, Kim O'Connor, Tomas Cieza, Nancy Coté, Paul Poirier, Pierre Douville, Jonatan Blais, Philippe Desmeules, Dimitris Kalavrouziotis, Siamak Mohammadi, Pierre Voisine, Mathieu Bernier, Philippe Pibarot, Sébastien Thériault
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Cardiac troponin is extensively used as a biomarker in modern medicine due to its diagnostic capability for myocardial injury, as well as its predictive and prognostic value for cardiac diseases. However, heterophile antibodies, antitroponin antibodi
Externí odkaz:
https://doaj.org/article/906c4f5612b145fd94fa43d346867346